Identification of ten variants associated with risk of estrogen-receptor-negative breast cancer

被引：268

作者：

Milne, Roger L. ^{[1
,2
]}

Kuchenbaecker, Karoline B. ^{[3
,4
]}

Michailidou, Kyriaki ^{[3
,5
]}

Beesley, Jonathan ^{[6
]}

Kar, Siddhartha ^{[7
]}

Lindstrom, Sara ^{[8
,9
]}

Hui, Shirley ^{[10
]}

Lemacon, Audrey ^{[11
]}

Soucy, Penny ^{[11
]}

Dennis, Joe ^{[3
]}

Jiang, Xia ^{[9
]}

Rostamianfar, Asha ^{[10
]}

Finucane, Hilary ^{[9
,12
]}

Bolla, Manjeet K. ^{[3
]}

McGuffog, Lesley ^{[3
]}

Wang, Qin ^{[3
]}

Aalfs, Cora M. ^{[13
]}

Adams, Marcia ^{[14
]}

Adlard, Julian ^{[15
]}

Agata, Simona ^{[16
]}

Ahmed, Shahana ^{[7
]}

Ahsan, Habibul ^{[17
]}

Aittomaki, Kristiina ^{[18
]}

Al-Ejeh, Fares ^{[19
]}

Allen, Jamie ^{[3
]}

Ambrosone, Christine B. ^{[20
]}

Amos, Christopher I. ^{[21
]}

Andrulis, Irene L. ^{[22
,23
]}

Anton-Culver, Hoda ^{[24
]}

Antonenkova, Natalia N. ^{[25
]}

Arndt, Volker ^{[26
]}

Arnold, Norbert ^{[27
]}

Aronson, Kristan J. ^{[28
,29
]}

Auber, Bernd ^{[30
]}

Auer, Paul L. ^{[31
,32
]}

Ausems, Margreet G. E. M. ^{[33
]}

Azzollini, Jacopo ^{[34
]}

Bacot, Francois ^{[35
,36
]}

Balmana, Judith ^{[37
]}

Barile, Monica ^{[38
]}

Barjhoux, Laure ^{[39
]}

Barkardottir, Rosa B. ^{[40
,41
]}

Barrdahl, Myrto ^{[42
]}

Barnes, Daniel ^{[3
]}

Barrowdale, Daniel ^{[3
]}

Baynes, Caroline ^{[7
]}

Beckmann, Matthias W. ^{[43
]}

Benitez, Javier ^{[44
,45
,46
]}

Bermisheva, Marina ^{[47
]}

Bernstein, Leslie ^{[48
]}

机构：

[1] Canc Council Victoria, Canc Epidemiol & Intelligence Div, Melbourne, Vic, Australia

[2] Univ Melbourne, Melbourne Sch Populat & Global Hlth, Ctr Epidemiol & Biostat, Melbourne, Vic, Australia

[3] Univ Cambridge, Dept Publ Hlth & Primary Care, Ctr Canc Genet Epidemiol, Cambridge, England

[4] Wellcome Trust Genome Campus, Wellcome Trust Sanger Inst, Hinxton, England

[5] Cyprus Inst Neurol & Genet, Dept Elect Microscopy Mol Pathol, Nicosia, Cyprus

[6] QIMR Berghofer Med Res Inst, Canc Div, Brisbane, Qld, Australia

[7] Univ Cambridge, Ctr Canc Genet Epidemiol, Dept Oncol, Cambridge, England

[8] Univ Washington, Sch Publ Hlth, Dept Epidemiol, Seattle, WA 98195 USA

[9] Harvard TH Chan Sch Publ Hlth, Program Genet Epidemiol & Stat Genet, Boston, MA USA

[10] Univ Toronto, Donnelly Ctr, Toronto, ON, Canada

[11] Laval Univ, Ctr Hosp Univ Quebec, Res Ctr, Genom Ctr, Quebec City, PQ, Canada

[12] MIT, Dept Math, Cambridge, MA 02139 USA

[13] Acad Med Ctr, Dept Clin Genet, Amsterdam, Netherlands

[14] Johns Hopkins Univ, Sch Med, Inst Med Genet, CIDR, Baltimore, MD USA

[15] Chapel Allerton Hosp, Yorkshire Reg Genet Serv, Leeds, W Yorkshire, England

[16] IRCCS, IOV, Immunol & Mol Oncol Unit, Padua, Italy

[17] Univ Chicago, Ctr Canc Epidemiol & Prevent, Chicago, IL 60637 USA

[18] Univ Helsinki, Helsinki Univ Hosp, Dept Clin Genet, Helsinki, Finland

[19] QIMR Berghofer Med Res Inst, personalised Med Team, Brisbane, Qld, Australia

[20] Roswell Pk Canc Inst, Buffalo, NY 14263 USA

[21] Dartmouth Coll, Ctr Genom Med, Dept Biomed Data Sci, Geisel Sch Med, 1 Med Ctr Dr, Lebanon, NH 03756 USA

[22] Mt Sinai Hosp, Lunenfeld Tanenbaum Res Inst, Fred A Litwin Ctr Canc Genet, Toronto, ON, Canada

[23] Univ Toronto, Dept Mol Genet, Toronto, ON, Canada

[24] Univ Calif Irvine, Dept Epidemiol, Irvine, CA USA

[25] NN Alexandrov Res Inst Oncol & Med Radiol, Minsk, BELARUS

[26] German Canc Res Ctr, Div Clin Epidemiol & Aging Res, Heidelberg, Germany

[27] Univ Hosp Schleswig Holstein, Christian Albrechts Univ Kiel, Inst Clin Mol Biol, Dept Gynecol & Obstet, Campus Kiel, Kiel, Germany

[28] Queens Univ, Dept Publ Hlth Sci, Kingston, ON, Canada

[29] Queens Univ, Canc Res Inst, Kingston, ON, Canada

[30] Hannover Med Sch, Inst Human Genet, Hannover, Germany

[31] Fred Hutchinson Canc Res Ctr, Canc Prevent Program, 1124 Columbia St, Seattle, WA 98104 USA

[32] Univ Wisconsin, Zilber Sch Publ Hlth, Milwaukee, WI 53201 USA

[33] Univ Med Ctr Utrecht, Dept Med Genet, Utrecht, Netherlands

[34] Fdn IRCCS, Ist Nazl Tumori, Dept Prevent & Predict Med, Unit Med Genet, Milan, Italy

[35] McGill Univ, Montreal, PQ, Canada

[36] Genom Quebec Innovat Ctr, Montreal, PQ, Canada

[37] Univ Hosp, Dept Med Oncol, Barcelona, Spain

[38] Ist Europeo Oncol, Div Canc Prevent & Genet, Milan, Italy

[39] Ctr Leon Berard, Batiment Cheney D, Lyon, France

[40] Landspitali, Dept Pathol, Lab Cell Biol, Reykjavik, Iceland

[41] Univ Iceland, BMC Biomed Ctr, Fac Med, Reykjavik, Iceland

[42] German Canc Res Ctr, Div Canc Epidemiol, Heidelberg, Germany

[43] Univ Hosp, Friedrich Alexander Univ Erlangen Nuremberg, Comprehens Canc Ctr Erlangen EMN, Dept Gynaecol & Obstet, Erlangen, Germany

[44] Spanish Natl Canc Res Ctr CNIO, Ctr Nacl Genotipado CEGEN, Human Genotyping Unit, Human Canc Genet Programme, Madrid, Spain

[45] Spanish Natl Canc Ctr CNIO, Human Genet Grp, Human Canc Genet Programme, Madrid, Spain

[46] Spanish Network Rare Dis CIBERER, Madrid, Spain

[47] Russian Acad Sci, Ufa Sci Ctr, Inst Biochem & Genet, Ufa, Russia

[48] Beckman Res Inst City Hope, Dept Populat Sci, Duarte, CA USA

[49] Univ Clermont Auvergne, INSERM, Ctr Jean Perrin, U1240,Imagerie Mol & Strategies Theranost, Clermont Ferrand, France

[50] Clin Canc Genet, Duarte, CA USA

来源：

NATURE GENETICS | 2017年 / 49卷 / 12期

基金：

美国国家卫生研究院; 加拿大健康研究院; 英国医学研究理事会;

关键词：

GENOME-WIDE ASSOCIATION; SUSCEPTIBILITY LOCI; CONFER SUSCEPTIBILITY; FUNCTIONAL VARIANTS; MUTATION CARRIERS; OVARIAN CANCERS; COMMON VARIANTS; MODIFIERS; ENHANCER; REVEALS;

D O I：

10.1038/ng.3785

中图分类号：

Q3 [遗传学];

学科分类号：

071007 ; 090102 ;

摘要：

Most common breast cancer susceptibility variants have been identified through genome-wide association studies (GWAS) of predominantly estrogen receptor (ER)-positive disease(1). We conducted a GWAS using 21,468 ER-negative cases and 100,594 controls combined with 18,908 BRCA1 mutation carriers (9,414 with breast cancer), all of European origin. We identified independent associations at P < 5 x 10(-8) with ten variants at nine new loci. At P < 0.05, we replicated associations with 10 of 11 variants previously reported in ER-negative disease or BRCA1 mutation carrier GWAS and observed consistent associations with ER-negative disease for 105 susceptibility variants identified by other studies. These 125 variants explain approximately 16% of the familial risk of this breast cancer subtype. There was high genetic correlation (0.72) between risk of ER-negative breast cancer and breast cancer risk for BRCA1 mutation carriers. These findings may lead to improved risk prediction and inform further fine-mapping and functional work to better understand the biological basis of ER-negative breast cancer.

引用

页码：1767 / 1778

页数：12

共 50 条

[21] Challenge in the treatment of estrogen-receptor-negative ductal carcinoma in situ
Altundag, K
JOURNAL OF CLINICAL ONCOLOGY, 2005, 23 (19) : 4469 - 4470
[22] POSTMENOPAUSAL ESTROGEN RECEPTOR POSITIVE BREAST CANCER AND OBESITY ASSOCIATED GENE VARIANTS
Ozgoz, Asuman
Icduygu, Fadime Mutlu
Yukselturk, Aysegul
Samli, Hale
Ozturk, Kuyas Hekimler
Baskan, Zuhal
Tutuncu, Ilknur
EXCLI JOURNAL, 2021, 20 : 1133 - 1144
[23] Diet quality is associated with the risk of estrogen receptor-negative breast cancer in postmenopausal women.
Fung, TT
Hu, FB
McCullough, ML
Newby, PK
Willett, WC
Holmes, MD
JOURNAL OF NUTRITION, 2006, 136 (02): : 466 - 472
[24] Estrogen receptor negative breast cancer.
Mccaskill-Stevens, W
CANCER EPIDEMIOLOGY BIOMARKERS & PREVENTION, 2002, 11 (10) : 1257S - 1257S
[25] Risk Factors That Increase Risk of Estrogen Receptor-Positive and -Negative Breast Cancer
Kerlikowske, Karla
Gard, Charlotte C.
Tice, Jeffrey A.
Ziv, Elad
Cummings, Steven R.
Miglioretti, Diana L.
JNCI-JOURNAL OF THE NATIONAL CANCER INSTITUTE, 2017, 109 (05):
[26] Moesin expression is associated with the estrogen receptor-negative breast cancer phenotype
Carmeci, C
Thompson, DA
Kuang, WW
Lightdale, N
Furthmayr, H
Weigel, RJ
SURGERY, 1998, 124 (02) : 211 - 217
[27] Radiosensitivity is associated with antitumor immunity in estrogen receptor-negative breast cancer
Kang, Byung-Hee
Jang, Bum-Sup
Kim, In Ah
BREAST CANCER RESEARCH AND TREATMENT, 2023, 197 (03) : 479 - 488
[28] Radiosensitivity is associated with antitumor immunity in estrogen receptor-negative breast cancer
Byung-Hee Kang
Bum-Sup Jang
In Ah Kim
Breast Cancer Research and Treatment, 2023, 197 : 479 - 488
[29] VEGF expression is associated with negative estrogen receptor status in patients with breast cancer
Fuckar, D
Dekanic, A
Stifter, S
Mustac, E
Krstulja, M
Dobrila, F
Jonjic, N
INTERNATIONAL JOURNAL OF SURGICAL PATHOLOGY, 2006, 14 (01) : 49 - 55
[30] Coffee consumption modifies risk of estrogen-receptor negative breast cancer
Li, J.
Humphreys, K.
Czene, K.
Liu, J.
Hall, P.
BREAST, 2011, 20 : S30 - S30

← 1 2 3 4 5 →